Embecta to host Analyst and Investor Day on May 22, 2025

GlobeNewswire

04-28

PARSIPPANY, N.J., April 28, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will hold an Analyst and Investor Day on May 22, 2025, from 9:00 a.m. to 12:30 p.m. in New York City.

Dev Kurdikar, President & Chief Executive Officer, and Jake Elguicze, Chief Financial Officer, will be joined by members of the embecta leadership team to present strategic and business overview, including value creation opportunities, the company’s financial profile and its long-term objectives.

To register for the webcast, please go to: embecta Analyst & Investor Day Webcast Registration.

Visit InvestorDay.embecta.com to view the agenda for the event and watch the live webcast. A replay of the webcast, along with Investor Day materials, will be available on the "Events & Presentations" section of the Company's Investor Relations website following the conclusion of the event.

In-person attendance is by invitation only.

About embecta
embecta is a global diabetes care company that is leveraging its 100-year legacy in insulin delivery to empower people with diabetes to live their best life through innovative solutions, partnerships, and the passion of approximately 2,000 employees around the globe. For more information, visit embecta.com or follow our social channels on LinkedIn, Facebook, and Instagram.

Contacts:

Media	Investors
Christian Glazar	Pravesh Khandelwal
Sr. Director, Corporate Communications	VP, Head of Investor Relations
908-821-6922	551-264-6547
Contact Media Relations	Contact IR

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2530704954"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2530704954\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2530704954?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-04-28 19:30","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2530704954","market":"us","top_or_hot":-1,"title":"Embecta to host Analyst and Investor Day on May 22, 2025","media":"GlobeNewswire","content":"<html><body><img hspace=\"5\" src=\"https://s.yimg.com/uu/api/res/1.2/UUZf1KBHjhuCnF24batLsA--/cT03NTthcHBpZD15dmlkZW9mZWVkczs-/https://media.zenfs.com/en/globenewswire.com/88b89c67eb25aa734a2e45950012ee2b\" title=\"Embecta_Logo.jpg\" vspace=\"5\"/>\n<p>PARSIPPANY, N.J., April 28, 2025 (GLOBE NEWSWIRE) -- <a href=\"https://laohu8.com/S/EMBC\">Embecta Corp.</a> (\"embecta\") (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will hold an Analyst and Investor Day on May 22, 2025, from 9:00 a.m. to 12:30 p.m. in New York City.</p>\n<p>Dev Kurdikar, President &amp; Chief Executive Officer, and Jake Elguicze, Chief Financial Officer, will be joined by members of the embecta leadership team to present strategic and business overview, including value creation opportunities, the company’s financial profile and its long-term objectives.</p>\n<p>To register for the webcast, please go to: embecta Analyst &amp; Investor Day Webcast Registration.</p>\n<p>Visit InvestorDay.embecta.com to view the agenda for the event and watch the live webcast. A replay of the webcast, along with Investor Day materials, will be available on the \"Events &amp; Presentations\" section of the Company's Investor Relations website following the conclusion of the event.</p>\n<p>In-person attendance is by invitation only.</p>\n<p><strong>About embecta </strong><br/>embecta is a global diabetes care company that is leveraging its 100-year legacy in insulin delivery to empower people with diabetes to live their best life through innovative solutions, partnerships, and the passion of approximately 2,000 employees around the globe. For more information, visit embecta.com or follow our social channels on LinkedIn, Facebook, and Instagram.<br/></p>\n<p><strong>Contacts:</strong><br/></p>\n<table>\n<tbody>\n<tr>\n<td>Media</td>\n<td>Investors</td>\n</tr>\n<tr>\n<td>Christian Glazar</td>\n<td>Pravesh Khandelwal</td>\n</tr>\n<tr>\n<td>Sr. Director, Corporate Communications</td>\n<td><a href=\"https://laohu8.com/S/VP..UK\">VP</a>, Head of Investor Relations</td>\n</tr>\n<tr>\n<td>908-821-6922</td>\n<td>551-264-6547</td>\n</tr>\n<tr>\n<td>Contact Media Relations</td>\n<td>Contact IR</td>\n</tr>\n</tbody>\n</table>\n<br/></body></html>","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Embecta to host Analyst and Investor Day on May 22, 2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEmbecta to host Analyst and Investor Day on May 22, 2025\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">GlobeNewswire</strong><span class=\"h-time small\">2025-04-28 19:30</span>\n</p>\n</h4>\n</header>\n<article>\n<html><body><img hspace=\"5\" src=\"https://s.yimg.com/uu/api/res/1.2/UUZf1KBHjhuCnF24batLsA--/cT03NTthcHBpZD15dmlkZW9mZWVkczs-/https://media.zenfs.com/en/globenewswire.com/88b89c67eb25aa734a2e45950012ee2b\" title=\"Embecta_Logo.jpg\" vspace=\"5\"/>\n<p>PARSIPPANY, N.J., April 28, 2025 (GLOBE NEWSWIRE) -- <a href=\"https://laohu8.com/S/EMBC\">Embecta Corp.</a> (\"embecta\") (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will hold an Analyst and Investor Day on May 22, 2025, from 9:00 a.m. to 12:30 p.m. in New York City.</p>\n<p>Dev Kurdikar, President &amp; Chief Executive Officer, and Jake Elguicze, Chief Financial Officer, will be joined by members of the embecta leadership team to present strategic and business overview, including value creation opportunities, the company’s financial profile and its long-term objectives.</p>\n<p>To register for the webcast, please go to: embecta Analyst &amp; Investor Day Webcast Registration.</p>\n<p>Visit InvestorDay.embecta.com to view the agenda for the event and watch the live webcast. A replay of the webcast, along with Investor Day materials, will be available on the \"Events &amp; Presentations\" section of the Company's Investor Relations website following the conclusion of the event.</p>\n<p>In-person attendance is by invitation only.</p>\n<p><strong>About embecta </strong><br/>embecta is a global diabetes care company that is leveraging its 100-year legacy in insulin delivery to empower people with diabetes to live their best life through innovative solutions, partnerships, and the passion of approximately 2,000 employees around the globe. For more information, visit embecta.com or follow our social channels on LinkedIn, Facebook, and Instagram.<br/></p>\n<p><strong>Contacts:</strong><br/></p>\n<table>\n<tbody>\n<tr>\n<td>Media</td>\n<td>Investors</td>\n</tr>\n<tr>\n<td>Christian Glazar</td>\n<td>Pravesh Khandelwal</td>\n</tr>\n<tr>\n<td>Sr. Director, Corporate Communications</td>\n<td><a href=\"https://laohu8.com/S/VP..UK\">VP</a>, Head of Investor Relations</td>\n</tr>\n<tr>\n<td>908-821-6922</td>\n<td>551-264-6547</td>\n</tr>\n<tr>\n<td>Contact Media Relations</td>\n<td>Contact IR</td>\n</tr>\n</tbody>\n</table>\n<br/></body></html>\n<div class=\"bt-text\">\n\n\n<p> 來源：<a href=\"https://finance.yahoo.com/news/embecta-host-analyst-investor-day-113000585.html\">GlobeNewswire</a></p>\n<p>為提升您的閱讀體驗，我們對本頁面進行了排版優化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"EMBC","symbol_name":"Embecta Corp.","start_time":0,"source_url":"https://finance.yahoo.com/news/embecta-host-analyst-investor-day-113000585.html","article_id":"2530704954","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2530704954","pubTimestamp":1745839800,"columns":[],"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"PARSIPPANY, N.J., April 28, 2025  -- Embecta Corp.  , a global diabetes care company with a 100-year legacy in insulin delivery, will hold an Analyst and Investor Day on May 22, 2025, from 9:00 a.m. to 12:30 p.m. in New York City.Dev Kurdikar, President & Chief Executive Officer, and Jake Elguicze, Chief Financial Officer, will be joined by members of the embecta leadership team to present strategic and business overview, including value creation opportunities, the company’s financial profile and its long-term objectives.To register for the webcast, please go to: embecta Analyst & Investor Day Webcast Registration.About embectaembecta is a global diabetes care company that is leveraging its 100-year legacy in insulin delivery to empower people with diabetes to live their best life through innovative solutions, partnerships, and the passion of approximately 2,000 employees around the globe. For more information, visitembecta.comor follow our social channels onLinkedIn,Facebook,and Insta","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"EMBC":"Embecta Corp.","BK4198":"医疗保健用品"},"translate_title":"Embecta将于2025年5月22日举办分析师和投资者日","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EMBC":0.9},"content_text":"PARSIPPANY, N.J., April 28, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (\"embecta\") (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will hold an Analyst and Investor Day on May 22, 2025, from 9:00 a.m. to 12:30 p.m. in New York City.\nDev Kurdikar, President & Chief Executive Officer, and Jake Elguicze, Chief Financial Officer, will be joined by members of the embecta leadership team to present strategic and business overview, including value creation opportunities, the company’s financial profile and its long-term objectives.\nTo register for the webcast, please go to: embecta Analyst & Investor Day Webcast Registration.\nVisit InvestorDay.embecta.com to view the agenda for the event and watch the live webcast. A replay of the webcast, along with Investor Day materials, will be available on the \"Events & Presentations\" section of the Company's Investor Relations website following the conclusion of the event.\nIn-person attendance is by invitation only.\nAbout embecta embecta is a global diabetes care company that is leveraging its 100-year legacy in insulin delivery to empower people with diabetes to live their best life through innovative solutions, partnerships, and the passion of approximately 2,000 employees around the globe. For more information, visit embecta.com or follow our social channels on LinkedIn, Facebook, and Instagram.\nContacts:\n\n\n\nMedia\nInvestors\n\n\nChristian Glazar\nPravesh Khandelwal\n\n\nSr. Director, Corporate Communications\nVP, Head of Investor Relations\n\n\n908-821-6922\n551-264-6547\n\n\nContact Media Relations\nContact IR","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}